Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases

被引:0
作者
Mostafa A. Sayed Ali
Eman Mohamed Hussein Khedr
Fatma Alzahraa Hassan Ahmed
Nada Nasr Eldin Mohamed
机构
[1] Assiut University,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Assiut University Hospital,Department of Neuropsychiatry, Faculty of Medicine
来源
International Journal of Clinical Pharmacy | 2018年 / 40卷
关键词
Clinical pharmacists; Drug-related problems; Egypt; Hospitalized patients; Neurology; Patient harm;
D O I
暂无
中图分类号
学科分类号
摘要
Background Drug-related problems (DRPs) are common in hospitalized patients with neurological diseases. Clinical pharmacy services could minimize drug-related harm and improve patient care. Objective To identify common DRPs in neurology and document clinical pharmacists’ medication-related interventions. Setting The wards and intensive care unit of the Department of Neurology at Assiut University Hospital. Method Prospective study of clinical pharmacists’ interventions during the routine care work of reviewing patients medical charts over a period of 6 months from January to June 2017. Main outcome measure The frequency and severity of DRPs and clinical pharmacists’ recommendations. Results Out of 1421 reviewed medications charts, a total of 414 DRPs were detected for 285 admitted patients. The most common DRPs were drug selection problems (36.7%) and dosing errors (27.5%). The majority of DRPs (71.7%) were categorized as causing no patient harm. Clinical pharmacists provided recommendations for the detected problems that ranged from drug monitoring to stop and starting new medicines. About 90% of pharmacists’ interventions were accepted by physicians. Poisson regression of factors that may influence the frequency of DRPs revealed significant associations of patient age (p = 0.03) and the number of comorbid diseases (p = 0.01). Conclusions Prescribing errors in neurology inpatient are likely to occur. Clinical pharmacists’ interventions assisted in early detection of drug problems and prevention of the consequent patient harms.
引用
收藏
页码:1257 / 1264
页数:7
相关论文
共 61 条
[51]  
Kane-Gill SL(undefined)undefined undefined undefined undefined-undefined
[52]  
Smithburger PL(undefined)undefined undefined undefined undefined-undefined
[53]  
Anthes AM(undefined)undefined undefined undefined undefined-undefined
[54]  
Seybert AL(undefined)undefined undefined undefined undefined-undefined
[55]  
Seden K(undefined)undefined undefined undefined undefined-undefined
[56]  
Kirkham JJ(undefined)undefined undefined undefined undefined-undefined
[57]  
Kennedy T(undefined)undefined undefined undefined undefined-undefined
[58]  
Lloyd M(undefined)undefined undefined undefined undefined-undefined
[59]  
James S(undefined)undefined undefined undefined undefined-undefined
[60]  
Mcmanus A(undefined)undefined undefined undefined undefined-undefined